These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15773967)

  • 1. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H; Morelon E; Noel LH; Mamzer-Bruneel MF; Legendre C; Peraldi MN; Kreis H
    Transpl Int; 2005 Apr; 18(4):458-60. PubMed ID: 15773967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report.
    Akash N
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):91-4. PubMed ID: 17237899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
    Jungraithmayr TC; Bulla M; Dippell J; Greiner C; Griebel M; Leichter HE; Plank C; Tönshoff B; Weber LT; Zimmerhackl LB;
    Pediatr Transplant; 2005 Apr; 9(2):226-31. PubMed ID: 15787798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of renal transplantation in focal glomerulosclerosis.
    Akioka K; Okamoto M; Wakabayashi Y; Nobori S; Ogino S; Ushigome H; Uryuhara K; Kaihara S; Yoshimura N
    Transplant Proc; 2006 Nov; 38(9):2819-22. PubMed ID: 17112838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation.
    Mitome J; Yamamoto H; Maruyama Y; Kobayashi A; Yaginuma T; Matsuo N; Tanno Y; Hayakawa H; Miyazaki Y; Yokoyama K; Utsunomiya Y; Yamaguchi Y; Hosoya T
    Clin Transplant; 2010 Jul; 24 Suppl 22():48-53. PubMed ID: 20590695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: a case report.
    Couloures K; Pepkowitz SH; Goldfinger D; Kamil ES; Puliyanda DP
    Pediatr Transplant; 2006 Dec; 10(8):962-5. PubMed ID: 17096767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients.
    Pardon A; Audard V; Caillard S; Moulin B; Desvaux D; Bentaarit B; Remy P; Sahali D; Roudot-Thoraval F; Lang P; Grimbert P
    Nephrol Dial Transplant; 2006 Apr; 21(4):1053-9. PubMed ID: 16364987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients.
    Senel MF; Van Buren CT; Etheridge WB; Barcenas C; Jammal C; Kahan BD
    Clin Nephrol; 1996 Jan; 45(1):18-21. PubMed ID: 8616952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.
    Kershaw DB; Sedman AB; Kelsch RC; Bunchman TE
    Clin Transplant; 1994 Dec; 8(6):546-9. PubMed ID: 7865917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ; Gera M; Amer H; Iqbal CW; Moore TB; Milliner DS; Cosio FG; Larson TS; Stegall MD; Ishitani MB; Gloor JM; Griffin MD
    Transplantation; 2009 Apr; 87(8):1232-9. PubMed ID: 19384172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
    Seso Simić D; Slavicek J; Bubić Filipi L; Puretić Z; Kes P
    Acta Med Croatica; 2003; 57(1):53-6. PubMed ID: 12876864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
    Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal segmental glomerulosclerosis and renal transplantation.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation.
    Shariatmadar S; Noto TA
    J Clin Apher; 2002; 17(2):78-83. PubMed ID: 12210710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.
    Meyer TN; Thaiss F; Stahl RA
    Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
    Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.